Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Bai, V. Dooslin Mercy
- Antimicrobial Susceptibility Pattern of Extended Spectrum of Beta Lactamase (ESBL) Producing Uropathogens from Pregnant Women
Abstract Views :594 |
PDF Views:445
Authors
Affiliations
1 Department of Biomedical Engineering, Sathyabama University, Chennai - 600 119, Tamil Nadu, IN
2 Center for Marine Science and Technology, Manonmaniam Sundaranar University, Rajakkamangalam - 629 501, Tamil Nadu, IN
3 Department of Biomedical Engineering, Rajiv Ganthi College of Enginnering and Technology,Puducherry - 607402, IN
1 Department of Biomedical Engineering, Sathyabama University, Chennai - 600 119, Tamil Nadu, IN
2 Center for Marine Science and Technology, Manonmaniam Sundaranar University, Rajakkamangalam - 629 501, Tamil Nadu, IN
3 Department of Biomedical Engineering, Rajiv Ganthi College of Enginnering and Technology,Puducherry - 607402, IN
Source
Indian Journal of Medicine and Healthcare, Vol 1, No 8 (2012), Pagination: 189-192Abstract
Extended spectrum of beta lactamase (ESBL) producing organisms create a major problem in clinical therapeutics. Antimicrobial resistant pattern of uropathogens were isolated from Government hospital, Thiruvanamalai district, Tamilnadu, India, during the period of January to June 2008. Total of 54 ESBL producing clinical isolates of gram negative bacilli were obtained from urine samples of 50 pregnant women. ESBL producers were detected of which 24(44.4%) isolates were E.coli, 20(37%) isolates were K.pneumoniae and 10(18.5%) isolates were P. aeruginosa. Out of 54 isolates 57.4%, 46.6% and 33.3% were resistant to Ampicillin, Amoxycillin and Ceftriaxone respectively. Of all isolates 100% susceptible to Ampicillin, Amoxycillin and Ceftriaxone combined with sulbactum and clavulanic acid showed synergistic effect. These combined drugs were found to be the choice for UTI infection to pregnant women. This study shows the frequency of drug resistant and ESBL producing E. coli, K. pneumoniae and P.aeruginosa is high in pregnant women. Advance drug resistance surveillance of ESBL isolates is need for perceptive use of antimicrobial agents.Keywords
Uropathogens, UTI, ESBL, Antimicrobial Susceptibility, Drug ResistantFull Text
References
- Alipourfard I and Nili NY (2010) Antibiogram of Extended Spectrum Beta-Lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolated from Hospital Samples. Bangladesh J. Med. Microbiol. 4(1), 32-36.
- Aminzadeh Z, Sadat KM and Shabani M (2008) Bacteriuria by extended spectrum Beta-lactamase producing E.coli and K. pneumoniae: isolates in a government hospital in south of Tehran, Iran. Iran J. Kidney Dis. 197-200.
- Babypadmini S and Appalaraju B (2004) Extended spectrum beta lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae prevalence and susceptibility pattern in a tertiary care hospital. Indian J.Med. Microbiol. 22(3), 172-174
- Bauer AW, Kirby WM, Sherris JC, Jurck M (1996) Antibiotic susceptibility testing by a standard single disc method. American J. Clin. Pathol. 451,493-496.
- Behrooozi A, Rahbar M and Yousefi JV (2010) Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. African J. Microbiol. Res. 4(9), 881-884.
- CLSI - Clinical and laboratory standard institute (2006) Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100-S CLSI, USA, Wayne. PA.
- Collee JG, Miles RS, and Watt B (1996) Test for the identification of bacteria. In: Collee, JG., AG Fraser BP Marmion A Simmons editors. Mackie & MacCartney practical medical microbiology, 14th ed. Edinburgh: Churchill Livingstone. pp: 151-179.
- Du B, Long Y, Liu H et al. (2002) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med.28, 1718-1723.
- Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M and Bokaei S (2006) Antibiotic resistant patterns and frequency of extended spectrum beta-lactamase producing isolates of K.pneumoniae in Tehran. Med. Sci. Monitor. 12,362-365.
- Grude NY. Tveten A Jenkins and Kristiansen BE (2005) Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment. Scandinavian J. Primary Health Care, 23, 115-119.
- Ho PL, Wong CWR, Yip KS, Loke SL, Leung MST, Mak GC, Chow FKH, Tsang KWT and Que TL (2007) Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagnostic Microbiol. Infectious Dis. 59, 439-445.
- Ho PL, Chow KH, Yuen KY, Ng WS and Chau PY (1998) Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum-lactamases in Escherichia coli and Klebsiella pneumonia. J. Antimicrobial Chemotherapy, 42, 49-54
- Hoepelman AIM, Meilland R and Geerlings SE (2003) Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int. J. Antimicrobial Agents, 22 (Suppl 2): S35-S43.
- Hooton TM, Besser R, Foxman B, Fritsche TR and Nicolle LE (2004) Acute uncomplicated cystis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin. Infectious Dis. 39, 75-80.
- Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The Eco. Sens study. Int. J. Antimicrobial Agents. 22(Suppl.2), 49-52.
- Khurana S, Taneja N and Sharma M (2002) Extended spectrum beta lactamases medialted resistance in urinary tract isolates of family Enterobacteriaceae. Indian J. Med.Res.116, 145-149.
- Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, Kim J and Kim EC (2002) Bloodstream infections by Extended-Spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome. Antimicrobial Agents & Chemotherapy. 46(5), 1481-1491.
- Marchese A, Gualco L, Debbia EA, Schito GC and Schito AM (2003) Invitro activity of fosfomycin against gram negative urinary pathogens and the biological cost of fosfomycin resistance. Int. J. Antimicrobial Agents. 22(Suppl 2): S53-S59.
- Mehrgan H and Rahbar M (2008) Prevalence of extended spectrum beta lactamase producing Escherichia coli in a tertiary care hospital in Tehran, Iran Int. J. Antimicrobial Agents, 31, 147-151.
- Metan G, Zarakolu P, Çakır B, Hascelik G and Uzun O (2005) Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Int. J. Antimicrobial Agents. 26(3), 254-257.
- Paterson DL (2006) Resistance in gram-negative bacteria: Enterobacteriaceae. American J. Med. 34, S20-S28.
- Ramesh N, Sumathi CS, Balasubramanian V, Palaniappan KR and Kannan VR (2008) Urinary tract infection and Antimicrobial susceptibility pattern of extended spectrum of beta lactamase producing clinical isolates. Adv. Biologi. Res. 2(5-6), 78-82.
- Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. DM Dis.-A- Month, 49, 71-82.
- Ronald AR, Nicolle LE, Stamm E, Kreger J, Warren J, Shaeffer A et al. (2001) Urinary tract infection in adults: research priorities and strategies. Int. J. Antimicrobial Agents.17, 343-348.
- Supriya ST, Suresh VJ, Sarfaraz A and Umesh H (2004) Evaluation of extended spectrum beta lactamases in urinary isolates. Indian J. Med. Res. 120, 553-556.
- Taneja N, Rao P, Arora J and Dogra A (2008) Occurrence of ESBL & Amp-C β-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. Indian J. Med. Res.127, 85-88.